| 000 | 01700 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513091344.0 | ||
| 264 | 0 | _c19960725 | |
| 008 | 199607s 0 0 eng d | ||
| 022 | _a0732-183X | ||
| 024 | 7 |
_a10.1200/JCO.1996.14.4.1291 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMilpied, N | |
| 245 | 0 | 0 |
_aAllogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cApr 1996 |
||
| 300 |
_a1291-6 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBone Marrow Transplantation _xmethods |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGraft vs Host Disease |
| 650 | 0 | 4 |
_aHodgkin Disease _xtherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProbability |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aFielding, A K | |
| 700 | 1 | _aPearce, R M | |
| 700 | 1 | _aErnst, P | |
| 700 | 1 | _aGoldstone, A H | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 14 _gno. 4 _gp. 1291-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.1996.14.4.1291 _zAvailable from publisher's website |
| 999 |
_c8647422 _d8647422 |
||